PRA Health Sciences ROA 2013-2018 | PRAH

Current and historical return on assets (ROA) values for PRA Health Sciences (PRAH) over the last 10 years.
Sector Industry Market Cap Revenue
Medical Medical Services $0.008B $2.259B
PRA Health Sciences, Inc. operates as a global contract research organizations providing outsourced clinical development services to the biotechnology and pharmaceutical industries. It offers therapeutic services in the areas of cardio-metabolic, biosimilars, infectious diseases, immunology, neurology and psychiatry, oncology and hematology, rare diseases, and respiratory needs. The Company engages in bioanalytical laboratory, clinical pharmacology, clinical development, strategic solutions, post marketing research, clinical informatics, clinical diagnostics, and safety and risk management activities. PRA Health Sciences, Inc. is based in Raleigh, North Carolina.
Stock Name Country Market Cap PE Ratio
Express Scripts Holding (ESRX) United States $45.769B 10.78
ICON (ICLR) Ireland $7.482B 25.11
Charles River Laboratories (CRL) United States $5.621B 21.85
INC Research Holdings (SYNH) United States $5.077B 22.35
Premier (PINC) United States $4.995B 20.20
HealthEquity (HQY) United States $4.978B 105.57
Teladoc (TDOC) United States $4.120B 0.00
NovoCure (NVCR) Jersey $3.002B 0.00
AMN Healthcare Services Inc (AMN) United States $2.850B 21.73
Intrexon (XON) United States $1.989B 0.00
BioTelemetry (BEAT) United States $1.615B 44.77
Medpace Holdings (MEDP) United States $1.589B 25.27
Healthways (TVTY) United States $1.449B 20.54
IKang Healthcare (KANG) China $1.419B 78.62
Natera (NTRA) United States $1.177B 0.00
China Cord Blood (CO) China $0.971B 25.97
Apollo Medical Holdings (AMEH) United States $0.777B 0.00
Surgery Partners (SGRY) United States $0.748B 0.00
Civitas Solutions (CIVI) United States $0.600B 15.28
CareDx (CDNA) United States $0.437B 0.00
OncoCyte (OCX) United States $0.124B 0.00
Interpace Diagnostics (IDXG) United States $0.026B 0.00
Cancer Genetics (CGIX) United States $0.024B 0.00
Biocept (BIOC) United States $0.016B 0.00
OpGen (OPGN) United States $0.012B 0.00
FORM Holdings (XSPA) United States $0.008B 0.00